Literature DB >> 18942752

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.

Reikei Matsuda1, Tomoko Koide, Chikako Tokoro, Tsuyoshi Yamamoto, Ten'i Godai, Taiki Morohashi, Yuji Fujita, Daisuke Takahashi, Ichiro Kawana, Shinichiro Suzuki, Satoshi Umemura.   

Abstract

BACKGROUND: Cytokines have validated roles in the immunopathogenesis of inflammatory bowel disease (IBD). This study was to investigate the expressions of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8, and IL-10 mRNAs in the colonic mucosa of patients with ulcerative colitis (UC) during active and quiescent UC.
METHODS: At colonoscopy, biopsies were taken from inflamed and non-inflamed mucosa of patients with steroid-naive UC (n = 15), non-IBD inflammatory colitis controls (ICC, n = 6), and non-colitis controls (NCC, n = 14). The presence of extensive mononuclear cells and neutrophils infiltrate in the lamina propria, cryptitis, and epithelial damage defined an inflammatory lesion in the mucosa. Quantitative cytokine mRNA expressions in biopsies were measured by real-time polymerase chain reaction (PCR).
RESULTS: Of 15 UC patients, 3 remitted with 5-aminosalicylate and 11 received granulocytapheresis; of these, 10 remitted. At baseline, IL-6, IL-8, TNF-alpha, and IL-10 mRNAs were high in inflamed mucosa compared with NCC (P < 0.01). In active UC, IL-6, IL-8 and IL-10 mRNAs were high compared with non-inflamed mucosa (P = 0.03, P = 0.03, P < 0.05, respectively). Both TNF-alpha mRNA (P = 0.03) and IL-6 mRNA (P = 0.04) were higher in UC compared with ICC. Even in non-inflamed mucosa, IL-8 and TNF-alpha mRNA expressions were high compared with NCC. Both IL-6 and IL-8 mRNAs decreased to normal levels after granulocytapheresis.
CONCLUSIONS: During active UC, all 4 cytokine mRNA levels were high; only IL-6 and IL-8 mRNAs decreased to normal levels during remission. IL-8 mRNA was high even at sites of endoscopically quiescent UC during active disease. Steroid naïve patients respond well to granulocytapheresis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942752     DOI: 10.1002/ibd.20759

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  32 in total

1.  Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.

Authors:  Xiaochang Liu; Jianming Xu; Qiao Mei; Liang Han; Jian Huang
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility.

Authors:  Bindu Chandrasekharan; Sabrina Jeppsson; Stefan Pienkowski; Denise D Belsham; Shanthi V Sitaraman; Didier Merlin; Efi Kokkotou; Asma Nusrat; Malu G Tansey; Shanthi Srinivasan
Journal:  Inflamm Bowel Dis       Date:  2013-11       Impact factor: 5.325

3.  Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis.

Authors:  B S Boland; D L Boyle; W J Sandborn; G S Firestein; B G Levesque; J Hillman; B Zhang; J Proudfoot; L Eckmann; P B Ernst; J Rivera-Nieves; S Pola; N Copur-Dahi; J T Chang
Journal:  Aliment Pharmacol Ther       Date:  2014-07-13       Impact factor: 8.171

4.  Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.

Authors:  Yoichiro Iboshi; Kazuhiko Nakamura; Keita Fukaura; Tsutomu Iwasa; Haruei Ogino; Yorinobu Sumida; Eikichi Ihara; Hirotada Akiho; Naohiko Harada; Makoto Nakamuta
Journal:  J Gastroenterol       Date:  2016-05-13       Impact factor: 7.527

Review 5.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

6.  Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing.

Authors:  Qiu-jie Zhao; Yan-bo Yu; Xiu-li Zuo; Yan-yan Dong; Yan-qing Li
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  Chemokine CXCL11 links microbial stimuli to intestinal inflammation.

Authors:  Z Liu; X Chen; X Wang; X Chen; C-H Song; Y Du; J Su; S A Yaseen; P-C Yang
Journal:  Clin Exp Immunol       Date:  2011-03-25       Impact factor: 4.330

8.  Cinnamaldehyde is the main mediator of cinnamon extract in mast cell inhibition.

Authors:  Yvonne Hagenlocher; Kristina Kiessling; Michael Schäffer; Stephan C Bischoff; Axel Lorentz
Journal:  Eur J Nutr       Date:  2014-12-11       Impact factor: 5.614

9.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

10.  TNFα causes thrombin-dependent vagal neuron apoptosis in inflammatory bowel disease.

Authors:  Danielle Fritze; Weizhen Zhang; Ji-Yao Li; Biaoxin Chai; Michael W Mulholland
Journal:  J Gastrointest Surg       Date:  2014-06-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.